Medical Cyclotron Market Growth, Size, Share, Trends, and Forecast 2032

Medical Cyclotron Market

Medical Cyclotron Market By Type (Azimuthally Varying Field (AVF) Cyclotron, Ring Cyclotron), By Product (Cyclotron 10-12 MeV, Cyclotron 16-18 MeV, Cyclotron 19-24 MeV, Cyclotron 24 MeV and Above), By Classification (Low Energy Medical Cyclotron, High Energy Medical Cyclotron), By Application (Diagnostic and Treatment, Research and Development, Others), By End User (Pharma Companies, Hospital, and Specialized Clinics), and By Region: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2024-2032

Category: Medical Device Report Format : PDF Report Code: ZMR-1887 Status : Upcoming
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 264.71 million USD 561.3 million 9.85% 2023

Description

The global Medical Cyclotron Market size accrued earnings worth approximately USD 264.71 Million in 2023 and is predicted to gain revenue of about USD 561.3 Million by 2032, is set to record a CAGR of nearly 9.85% over the period from 2023 to 2032.

Global Medical Cyclotron Market sizeRequest Free Sample

Global Medical Cyclotron Market: Overview

It is basically a machine which is used widely in the medical imaging and research field. A cyclotron machine accelerates the hybrid atom to a very high speed. The main benefit of using the cyclotron instead of purchasing the isotopes for the medical applications is increased efficiency in the treatment. This is due to the fact that isotopes have short life; by the time the isotope will reach its destination half of the life will be utilized. On the other hand, if a cyclotron is present in the medical facility the number of scans that are given to the patients can be increased and there will be reduction in the cost. In order to ensure secure operations, the medical facility that makes use of the cyclotron should be built with extreme safety measures such as constant monitoring and multiple levels of shielding.

Global Medical Cyclotron Market: Growth Factors

The increased number of cases of the chronic disease cancer is the key factor that is driving the medical cyclotron market. For the advanced treatment procedures, increased investments are being made thus fuelling the growth of the market. Other factors that will trigger the medical cyclotron market are growing geriatric population, increasing disposable economy, and change in the lifestyles. The increase in the awareness regarding the use of cyclotrons in the diagnosis application of the deep-lying tumors is positively affecting the growth of the market. There are certain factors that are negatively affecting the growth of the market which include strict regulations that are implemented by the government, high cost coupled with the procedures and the lack of practice.

Medical Cyclotron MarketRequest Free Sample

Medical Cyclotron Market: Report Scope

Report Attributes Report Details
Report Name Medical Cyclotron Market
Market Size in 2023 USD 264.71 Million
Market Forecast in 2032 USD 561.3 Million
Growth Rate CAGR of 9.85%
Number of Pages 203
Key Companies Covered GENERAL ELECTRIC COMPANY, Best Cyclotron Systems, Inc., Ionetix Corporation, Varian Medical Systems, Inc., IBA Radiopharma Solutions, Advanced Cyclotron Systems, Nuclear Healthcare Limited, Sumitomo Heavy Industries, Ltd., isoSolution Inc., Siemens Healthcare Private Limited, ALCEN, Ebco Industries Ltd., ANSTO, UNGER Medizintechnik GmbH & Co.KG, Trasis, Best ABT Molecular Imaging, Inc., Lightpoint Medical, Atulaya Healthcare, Vega Medical, Global Medical Solutions, among other
Segments Covered By Type, By Product, By Classification, By Application, By End User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Medical Cyclotron Market: Segmentation

The global medical cyclotron market is segmented based on type, product, classification, application, end user, and region.

By Type Insights

Based on Type, the global medical cyclotron market is divided into azimuthally varying field (AVF) cyclotron, ring cyclotron. An Azimuthally Varying Field (AVF) Cyclotron segment is a type of particle accelerator that uses a magnetic field with varying intensity around the cyclotron's azimuth (circular path). This variation helps to focus the particles as they spiral outward, maintaining their path and energy more effectively. The AVF cyclotron's design enables higher stability and efficiency in accelerating particles, making it ideal for producing medical isotopes used in diagnostic imaging and radiotherapy. The AVF cyclotron is commonly used in hospitals and research institutions for the production of positron-emitting isotopes such as Fluorine-18, which is critical for PET scans. Its ability to produce high-energy beams also makes it suitable for certain therapeutic applications, including proton therapy for cancer treatment. The azimuthal variation in the magnetic field ensures better beam focus and stability.

A Ring Cyclotron segment is a type of cyclotron that features a ring-shaped accelerator cavity. Unlike the traditional cyclotron where particles spiral outwards in a flat disc shape, the ring cyclotron accelerates particles in a circular path within a doughnut-shaped ring. This design allows for continuous acceleration and is particularly useful for achieving very high energies. Ring cyclotrons are typically used in large-scale research facilities and specialized medical centers. They are capable of producing high-energy beams necessary for advanced research in particle physics and for therapeutic applications such as proton and heavy ion therapy, which require precise and high-energy beams to target and destroy cancer cells. The ring design allows for continuous particle acceleration, achieving higher energies than conventional cyclotrons.

By Product Insights

On the basis of Product, the global medical cyclotron market is bifurcated into cyclotron 10-12 MeV, cyclotron 16-18 MeV, cyclotron 19-24 MeV, cyclotron 24 MeV and above. Cyclotron 10-12 MeV energy range segment is primarily used in the production of positron-emitting isotopes such as Fluorine-18, essential for positron emission tomography (PET) scans. These cyclotrons are typically utilized in hospitals and specialized radiopharmacies for creating radiopharmaceuticals used in diagnostic imaging. The compact size and affordability of these cyclotrons make them accessible to a wider range of medical facilities, providing a cost-effective solution for producing high-demand isotopes for routine diagnostic procedures. The segment is projected to grow due to the increasing demand for PET scans and the convenience offered by these cyclotrons.

Cyclotrons in the 16-18 MeV range segment is versatile and widely used for producing a variety of isotopes for both diagnostic and therapeutic purposes. These cyclotrons are prevalent in larger hospitals and centralized radio pharmacies, supporting the production of isotopes such as Gallium-68, Copper-64, and Iodine-124, used in PET imaging and targeted radiotherapy. Their higher production capacity and flexibility make them suitable for both clinical and research applications, contributing to the segment's significant growth.

Cyclotron 19-24 MeV energy range segment is designed for high-volume production, often used in commercial radiopharmacy and large research institutions. These cyclotrons produce a wide array of isotopes, including therapeutic ones like Yttrium-90 and Zirconium-89, used in various forms of radiotherapy. The segment is driven by the need for high-throughput production and the versatility to produce diverse isotopes, making these cyclotrons crucial for large-scale medical and industrial applications.

Cyclotrons operating at 24 MeV and above segment is highly specialized, typically found in large research institutions and commercial radio pharmacies that require extensive isotope production capabilities. These cyclotrons can produce a wide variety of high-energy isotopes used in advanced medical treatments and research. They are essential for applications requiring continuous acceleration and high-energy beams, such as advanced particle physics research and specialized cancer treatments. This segment is expected to see substantial growth due to the increasing demand for advanced medical research and high-energy isotopes.

By Classification Insights

Based on Classification, the global medical cyclotron market is categorized into low energy medical cyclotron, and high energy medical cyclotron. Low-energy medical cyclotrons segment typically operate at energies ranging from 10 to 18 MeV (Mega Electron Volts). These cyclotrons are primarily used for producing radioisotopes that are common in PET (Positron Emission Tomography) imaging, such as Fluorine-18. The compact size and relatively lower operational costs make low-energy cyclotrons particularly suitable for hospitals and diagnostic centers.

High energy medical cyclotrons segment operates at energies above 18 MeV and can reach up to 30 MeV or more. These cyclotrons are capable of producing a wider range of radioisotopes, including those required for both diagnostic and therapeutic purposes. Their higher energy levels allow for the production of isotopes with longer half-lives, suitable for wider distribution.

By Application Insights

By Application, the global medical cyclotron market is divided into diagnostic and treatment, research and development, and others. In the diagnostic and treatment segment medical cyclotrons play a crucial role in both diagnostic imaging and treatment. These applications primarily involve the production of radioisotopes used in various nuclear medicine procedures. The isotopes generated by cyclotrons are essential for positron emission tomography (PET) scans, single-photon emission computed tomography (SPECT) scans, and certain therapeutic procedures.

In addition to their clinical applications, medical cyclotrons are pivotal in research and development (R&D) within nuclear medicine and other scientific fields. They enable the production of a wide range of radioisotopes necessary for scientific studies and the development of new medical technologies.

By End User Insights

In terms of End User, the global medical cyclotron market is bifurcated into pharma companies, hospital, and specialized clinics. Pharmaceutical companies primarily utilize medical cyclotrons for the production of radiopharmaceuticals, which are crucial for diagnostic and therapeutic applications, especially in oncology and cardiology. They focus on synthesizing isotopes such as F-18, C-11, and Tc-99m and are heavily invested in research and development for new diagnostic and therapeutic agents. The key drivers for pharmaceutical companies include high R&D investments and increasing regulatory approvals, though they face challenges related to stringent regulatory compliance and high operational costs.

Hospitals use medical cyclotrons to support in-house diagnostic imaging and therapeutic procedures, which enhances their ability to provide comprehensive medical care. Applications in hospitals include the production of PET and SPECT isotopes for imaging procedures and the use of radiopharmaceuticals in cancer treatment. The growing demand for advanced diagnostic imaging and personalized treatment options, coupled with technological integration, are significant drivers for hospitals. However, the high initial investment, space requirements, and the need for skilled personnel to operate cyclotrons pose considerable challenges.

Specialized clinics, particularly those focusing on oncology and cardiology, utilize medical cyclotrons to offer advanced diagnostic and therapeutic services. These clinics provide precision diagnostics through PET and SPECT scans and deliver targeted radiopharmaceutical therapies for conditions like cancer. The high demand for specialized services and the effectiveness of radiopharmaceuticals in improving patient outcomes are key drivers for these clinics. Nonetheless, they must manage high operational costs and ensure compliance with health and safety regulations.

Global Medical Cyclotron Market: Regional Analysis

The market for medical cyclotron is geographically diversified into the Middle East & Africa, Eastern Europe, North America, Western Europe, Latin America, and Asia Pacific. The region that is dominating the medical cyclotron market is the North America and it will continue its dominance in the coming years too. The factors that are driving the medical cyclotron market in the North American region is the increased initiatives that are taken by the government, the developed economic condition, and the growing business investments. The second leading region in the medical cyclotron market is Latin America which is followed by Europe. The driving factors that are influencing the market growth are the increasing interest towards the racing competitions and the high awareness among the population.

Global Medical Cyclotron Market: Competitive Players

The key market players that are involved in the medical cyclotron market include

  • GENERAL ELECTRIC COMPANY
  • Best Cyclotron Systems Inc.
  • Ionetix Corporation
  • Varian Medical Systems Inc.
  • IBA Radiopharma Solutions
  • Advanced Cyclotron Systems
  • Sumitomo Heavy  Ltd.
  • isoSolution Inc.
  • Siemens Healthcare Private Limited
  • Nuclear Healthcare Limited
  • ALCEN
  • Ebco Industries Ltd.
  • ANSTO
  • UNGER Medizintechnik GmbH & Co.KG
  • Trasis
  • Best ABT Molecular Imaging Inc.
  • Lightpoint Medical
  • Atulaya Healthcare
  • Vega Medical
  • Global Medical Solutions
  • among other

Global Medical Cyclotron Market: Segment Analysis

By Type

  • Azimuthally Varying Field (AVF) Cyclotron
  • Ring Cyclotron

By Product

  • Cyclotron 10-12 MeV
  • Cyclotron 16-18 MeV
  • Cyclotron 19-24 MeV
  • Cyclotron 24 MeV and Above

By Classification

  • Low Energy Medical Cyclotron
  • High Energy Medical Cyclotron Type

By Application

  • Diagnostic and Treatment
  • Research and Development
  • Others

By End User

  • Pharma Companies
  • Hospital
  • Specialized Clinics

By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed